Miguel Urioste

Miguel Urioste


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
OCOriol Calvete
Oriol Calvete
PMPaula Martinez
Paula Martinez
PGPablo Garcia-Pavia
Pablo Garcia-Pavia
CBCarlos Benitez-Buelga
Carlos Benitez-Buelga
BPBeatriz Paumard-Hernández
Beatriz Paumard-Hernández
JBJavier Benítez
Javier Benítez
Cardiac angiosarcoma (CAS) is a rare malignant tumour whose genetic basis is unknown. Here we show, by whole-exome sequencing of a TP53-negative Li–Fraumeni-like (LFL) family including CAS cases, that a missense variant (p.R117C) in POT1 (protection of telomeres 1) gene is responsible for CAS. The same gene alteration is found in two other LFL families with CAS, supporting the causal effect of the identified mutation. We extend the analysis to TP53-negative LFL families with no CAS and find the same mutation in a breast AS family. The mutation is recently found once in 121,324 studied alleles in ExAC server but it is not described in any other database or found in 1,520 Spanish controls. In silico structural analysis suggests how the mutation disrupts POT1 structure. Functional and in vitro studies demonstrate that carriers of the mutation show reduced telomere-bound POT1 levels, abnormally long telomeres and increased telomere fragility.

10 July 2013 in European Journal of Human Genetics
Verified
Journal Article
Closed access
BRB Rivera
B Rivera
JPJ Perea
J Perea
ESE Sánchez
E Sánchez
MVM Villapún
M Villapún
ESE Sánchez-Tomé
E Sánchez-Tomé
MUMiguel Urioste
Miguel Urioste

17 May 2004 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
MUMiguel Urioste
Miguel Urioste
MGM. del Carmen Garcia‐Andrade
M. del Carmen Garcia‐Andrade
Laura ValleLaura Valle
Laura Valle
MRMercedes Robledo
Mercedes Robledo
FGFernando González‐Palacios
Fernando González‐Palacios
JBJavier Benítez
Javier Benítez

5 October 2010 in Annals of Oncology
Verified
Journal Article
Closed access
PDF file
BRB. Rivera
B. Rivera
SGS. González
S. González
ESE. Sánchez-Tomé
E. Sánchez-Tomé
Ignacio BlancoIgnacio Blanco
Ignacio Blanco
FMF. Mercadillo
F. Mercadillo
MUMiguel Urioste
Miguel Urioste
Background: Classical familial adenomatous polyposis (FAP) is characterized by the appearance of >100 colorectal adenomas. Patients and Methods: We screened the APC and MUTYH genes for mutations and evaluated the genotype–phenotype correlation in 136 Spanish classical FAP families. Results:APC/MUTYH mutations were detected in 107 families. Sixty-four distinct APC point mutations were detected in 95 families of which all were truncating mutations. A significant proportion (39.6%) had not been previously reported. Mutations were spread over the entire coding region and great rearrangements were identified in six families. Another six families exhibited biallelic MUTYH mutations. No APC or MUTYH mutations were detected in 29 families. These APC/MUTYH-negative families showed clinical differences with the APC-positive families. A poor correlation between phenotype and mutation site was observed. Conclusions: Our results highlight that a broad approach in the genetic study must be considered for classical FAP due to involvement of both APC and MUTYH and the heterogeneous spectrum of APC mutations observed in this Spanish population. The scarcely consistent genotype–phenotype correlation does not allow making specific recommendations regarding screening and management. Differences observed in APC/MUTYH-negative families may reflect a genetic basis other than mutations in APC and MUTYH genes for FAP predisposition.

Verified
Journal Article
Open access
PDF file
EÁEdurne Álvaro
Edurne Álvaro
JCJuana M Cano
Juana M Cano
JGJuan Garcia
Juan Garcia
LBLorena Brandáriz
Lorena Brandáriz
SOSusana Olmedillas-López
Susana Olmedillas-López
JPJosé Perea
José Perea
Our aim was to characterize and validate that the location and age of onset of the tumor are both important criteria to classify colorectal cancer (CRC). We analyzed clinical and molecular characteristics of early-onset CRC (EOCRC) and late-onset CRC (LOCRC), and we compared each tumor location between both ages-of-onset. In right-sided colon tumors, early-onset cases showed extensive Lynch syndrome (LS) features, with a relatively low frequency of chromosomal instability (CIN), but a high CpG island methylation phenotype. Nevertheless, late-onset cases showed predominantly sporadic features and microsatellite instability cases due to BRAF mutations. In left colon cancers, the most reliable clinical features were the tendency to develop polyps as well as multiple primary CRC associated with the late-onset subset. Apart from the higher degree of CIN in left-sided early-onset cancers, differential copy number alterations were also observed. Differences among rectal cancers showed that early-onset rectal cancers were diagnosed at later stages, had less association with polyps, and more than half of them were associated with a familial LS component. Stratifying CRC according to both location and age-of-onset criteria is meaningful, not only because it correlates the resulting categories with certain molecular bases, but with the confirmation across larger studies, new therapeutical algorithms could be defined according to this subclassification.

9 November 2014 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
ESE. Sánchez-Tomé
E. Sánchez-Tomé
BRB. Rivera
B. Rivera
JPJ. Perea
J. Perea
GPG. Pita
G. Pita
DRDaniel Rueda
Daniel Rueda
MUMiguel Urioste
Miguel Urioste